Kyverna Therapeutics, Inc. (KYTX) › EPS (Diluted)Kyverna Therapeutics, Inc. (KYTX) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2023: $-89.612024: $-3.332025: $-3.64$-3.642023EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-3.64-9.3%2024$-3.33+96.3%2023$-89.61—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share